Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Halogenated hydrocarbon doai
Patent
1982-06-10
1985-04-16
Warden, Robert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Halogenated hydrocarbon doai
424 89, 435238, 514758, A61K 3514, A61K 3912, A61K 3102, C12N 706
Patent
active
045115567
ABSTRACT:
A method of inactivating a lipid virus in a protein carrier selected from the group consisting of Hepatitis B virus (HBV) and non-A, non-B hepatitis (NANBH) by contacting said virus for an extended period of time and ambient temperature with a halohydrocarbon treating agent preferably chloroform in an amount of 5% v/v to 50% v/v.
REFERENCES:
patent: 4031204 (1980-10-01), Davis
patent: 4230697 (1977-06-01), Nishida et al.
patent: 4302444 (1981-11-01), Baxendale
Purcell, "The Hepatitis Viruses: An Overview and Historical Perspective," Viral Hepatitis, 1981, Franklin Institute Press.
Maramorosch et al., Methods in Virology, vol. 2, 1967.
Feinstone Stephen M.
Purcell Robert H.
Foley Shawn P.
Roberts, Jr. John S.
The United States of America as represented by the Department of
Warden Robert J.
LandOfFree
Inactivation of a lipid virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inactivation of a lipid virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inactivation of a lipid virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1455470